Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP666037.RAhGD7SvcJdamxWT75VrljOFrwJLzHqipONq-_sq42YUU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP666037.RAhGD7SvcJdamxWT75VrljOFrwJLzHqipONq-_sq42YUU130_assertion type Assertion NP666037.RAhGD7SvcJdamxWT75VrljOFrwJLzHqipONq-_sq42YUU130_head.
- NP666037.RAhGD7SvcJdamxWT75VrljOFrwJLzHqipONq-_sq42YUU130_assertion wasGeneratedBy ECO_0000203 NP666037.RAhGD7SvcJdamxWT75VrljOFrwJLzHqipONq-_sq42YUU130_provenance.
- NP666037.RAhGD7SvcJdamxWT75VrljOFrwJLzHqipONq-_sq42YUU130_assertion wasDerivedFrom befree-20150227 NP666037.RAhGD7SvcJdamxWT75VrljOFrwJLzHqipONq-_sq42YUU130_provenance.
- NP666037.RAhGD7SvcJdamxWT75VrljOFrwJLzHqipONq-_sq42YUU130_assertion SIO_000772 20194893 NP666037.RAhGD7SvcJdamxWT75VrljOFrwJLzHqipONq-_sq42YUU130_provenance.
- NP666037.RAhGD7SvcJdamxWT75VrljOFrwJLzHqipONq-_sq42YUU130_assertion evidence source_evidence_literature NP666037.RAhGD7SvcJdamxWT75VrljOFrwJLzHqipONq-_sq42YUU130_provenance.
- NP666037.RAhGD7SvcJdamxWT75VrljOFrwJLzHqipONq-_sq42YUU130_assertion description "[Patients with refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) are difficult to treat because the cytoreductive treatment might be beneficial for the thrombocytosis component but harmful for the RARS component.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666037.RAhGD7SvcJdamxWT75VrljOFrwJLzHqipONq-_sq42YUU130_provenance.